Drug trafficking and controlled substances

HR 4016: Department of Defense Appropriations Act, 2026

Department of Defense Appropriations Act, 2026

This bill provides FY2026 appropriations to the Department of Defense (DOD) for military activities.

(The bill excludes military construction, military family housing, civil works projects of the Army Corps of Engineers, and nuclear warheads, which are all included in other appropriations bills.)

Within the DOD budget, the bill provides appropriations for

  • Military Personnel;
  • Operation and Maintenance;
  • Procurement;
  • Research, Development, Test and Evaluation; and
  • Revolving and Management Funds.

The bill provides appropriations for Other Department of Defense Programs, including

  • the Defense Health Program,
  • Chemical Agents and Munitions Destruction,
  • Drug Interdiction and Counter-Drug Activities, and
  • the Office of the Inspector General.

In addition, the bill provides appropriations for Related Agencies, including (1) the Central Intelligence Agency Retirement and Disability System Fund, and (2) the Intelligence Community Management Account.

The bill also sets forth requirements and restrictions for using funds provided by this and other appropriations acts.

HR 2827: To provide for the equitable settlement of certain Indian land disputes regarding land in Illinois, and for other purposes.

This bill confers jurisdiction to the U.S. Court of Federal Claims for the Miami Tribe of Oklahoma’s land claim arising under the Treaty of Grouseland. The court must render judgement without regard to the statute of limitations or any delay-based defense. This jurisdiction expires unless such a claim is filed within one year.

All other claims, including any future claims, of the tribe to land in Illinois are extinguished.

HR 2483: SUPPORT for Patients and Communities Reauthorization Act of 2025

SUPPORT for Patients and Communities Reauthorization Act of 2025

This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.

For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to

•    addressing substance use disorders with respect to pregnant and postpartum women,
•    prevention and recovery from substance use disorders for youth, 
•    housing for individuals in recovery from substance use disorders,
•    community organizations facilitating recovery from substance use disorders,
•    loan repayment for certain health care providers treating substance use disorders, 
•    prevention of overdoses of controlled substances,
•    treatment of children experiencing psychological trauma, and
•    mental and behavioral health education and training for medical and allied health students.

Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.

Additionally, the bill establishes new requirements for HHS, including requirements relating to

•    protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
•    establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
•    reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

HR 2351: To direct the Commandant of the Coast Guard to update the policy of the Coast Guard regarding the use of medication to treat drug overdose, and for other purposes.

This bill requires the Coast Guard to provide access to naloxone (a medication to reverse opioid overdoses) at its facilities, track distribution of the medication, and monitor the illegal use of of controlled substances. 

The bill directs the Coast Guard to update its policy regarding the use of medication to treat drug overdoses to require naloxone or a similar medication to be made available to members on all Coast Guard installations and in each operational environment. 

Further, the Coast Guard must participate in the Department of Defense (DOD) tracking system for naloxone distribution and the illegal use of fentanyl and other controlled substances. (The National Defense Authorization Act for Fiscal Year 2024 directed DOD to establish the tracking system.) The bill requires the Coast Guard to finalize a memorandum of understanding with DOD to facilitate Coast Guard access to the tracking system.

The bill also specifies that laws that prohibit manufacturing or distributing controlled substances on vessels apply when controlled substances are intentionally or knowingly placed or caused to be placed on board a vessel (e.g., without the crew’s knowledge or on board an unmanned vessel). 

Further, the bill requires the Coast Guard to brief Congress within two years after the bill’s enactment about the use of opioids and overdose medication at Coast Guard facilities by members and personnel. The briefing must describe the Coast Guard’s progress in implementing its updated policy, the prevalence and incidence of the illegal use of controlled  substances, and its processes to mitigate substance abuse.

HR 1563: STOP Fentanyl and Xylazine Act

Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act or the STOP Fentanyl and Xylazine Act

This bill exempts the possession, sale, purchase, import, export, or transport of equipment that tests for the presence of fentanyl or xylazine from criminal penalties under the Controlled Substances Act.

Sponsors

Jasmine Crockett (D) TX

Cosponsors

Lance Gooden (R) TX

Introduced on
Tuesday, February 25th, 2025

Subjects
,

HR 1561: ALERT Communities Act

Advancing Lifesaving Efforts with Rapid Test strips for Communities Act or the ALERT Communities Act

This bill establishes programs and requirements to advance the development and usage of test strips that detect the presence of certain hazardous drugs (e.g., fentanyl, xylazine).

Currently, the Substance Abuse and Mental Health Services Administration provides grants to government entities to train and provide authorized equipment to first responders and other relevant personnel for emergency treatment of opioid overdoses. The bill expands these grants to include rapid response test strips for detecting the presence of fentanyl, xylazine, and other synthetic opioids or emerging substances in people or within other drugs.

Additionally, the bill requires the Department of Health and Human Services (HHS) to publish guidance and standards for test strip manufacturers to support the development, evaluation, and authorization of test strips.

Also, HHS must conduct a study and report to Congress on how the availability and usage of test strips and similar equipment impacts the frequency of overdoses and participation in substance use disorder treatment. 

HR 1577: Stop Fentanyl Money Laundering Act of 2025

Stop Fentanyl Money Laundering Act of 2025

This bill expands efforts to prevent money laundering related to international fentanyl and narcotics distribution.

The bill allows the Department of the Treasury to impose restrictions on an entity or activity determined to be of primary money-laundering concern in connection with illicit fentanyl and narcotics trafficking. Specifically, if Treasury determines that a foreign financial institution, class of transaction, or type of account is of such concern, Treasury may require domestic financial institutions and agencies to take special measures, such as reporting certain financial transactions involving that entity or activity.

The Financial Crimes Enforcement Network (FinCEN) must issue advisories to financial institutions about how to identify Chinese money laundering that facilitates the trafficking of fentanyl and other synthetic opioids. FinCEN must also issue guidance to financial institutions for filing suspicious transaction reports related to suspected narcotics trafficking by transnational criminal organizations.